CorVel Co. (NASDAQ:CRVL) Shares Purchased by Neuberger Berman Group LLC

Neuberger Berman Group LLC grew its holdings in shares of CorVel Co. (NASDAQ:CRVL) by 204.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 845,531 shares of the business services provider’s stock after buying an additional 567,984 shares during the period. Neuberger Berman Group LLC’s holdings in CorVel were worth $94,074,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Bessemer Group Inc. boosted its stake in shares of CorVel by 6,350.0% during the 4th quarter. Bessemer Group Inc. now owns 258 shares of the business services provider’s stock worth $29,000 after acquiring an additional 254 shares in the last quarter. Fifth Third Bancorp lifted its stake in shares of CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock worth $36,000 after purchasing an additional 101 shares during the period. Jones Financial Companies Lllp purchased a new position in shares of CorVel during the 4th quarter worth $37,000. US Bancorp DE increased its holdings in shares of CorVel by 225.4% during the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock worth $43,000 after buying an additional 266 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of CorVel by 175.2% during the 4th quarter. GAMMA Investing LLC now owns 432 shares of the business services provider’s stock worth $48,000 after buying an additional 275 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised CorVel from a “hold” rating to a “buy” rating in a research report on Tuesday.

Insider Buying and Selling

In other news, Director Alan Hoops sold 10,200 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the transaction, the director now directly owns 118,213 shares in the company, valued at $13,758,811.07. The trade was a 7.94 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Steven J. Hamerslag sold 10,000 shares of the business’s stock in a transaction on Thursday, February 6th. The shares were sold at an average price of $123.48, for a total transaction of $1,234,800.00. Following the transaction, the director now owns 314,000 shares in the company, valued at approximately $38,772,720. This represents a 3.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 32,200 shares of company stock valued at $3,824,115 over the last quarter. Corporate insiders own 47.57% of the company’s stock.

CorVel Price Performance

NASDAQ:CRVL opened at $115.56 on Thursday. CorVel Co. has a 12 month low of $76.20 and a 12 month high of $128.61. The firm has a market capitalization of $5.94 billion, a PE ratio of 67.98 and a beta of 0.94. The business’s 50-day moving average is $111.80 and its two-hundred day moving average is $114.92.

CorVel (NASDAQ:CRVL) last issued its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.